Johnson & Johnson Stock Holds Steady Amid Strong Q2 Earnings

Johnson & Johnson stock held firm on strong Q2 results, opening at $265.91 on September 12, 2026, with a market capitalization of $640.82 billion.

The company's second-quarter revenue was $25.31 billion, up 6.6 percent year over year, while earnings per share (EPS) came in at $2.90, beating the consensus estimate by $0.06.

RBC Capital maintained its 'Buy' rating on Johnson & Johnson stock, with a price target of $287.59, representing a 7.68 percent upside from current levels.